Insight Molecular Diagnostics Net Income 2014-2025 | IMDX
Insight Molecular Diagnostics net income from 2014 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Insight Molecular Diagnostics Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-61 |
| 2023 | $-29 |
| 2022 | $-73 |
| 2021 | $-64 |
| 2020 | $-30 |
| 2019 | $-22 |
| 2018 | $-16 |
| 2017 | $-19 |
| 2016 | $-11 |
| 2015 | $-9 |
| 2014 | $-5 |
| 2013 | $-3 |
| Insight Molecular Diagnostics Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-10 |
| 2025-03-31 | $-7 |
| 2024-12-31 | $-34 |
| 2024-09-30 | $-13 |
| 2024-06-30 | $-5 |
| 2024-03-31 | $-9 |
| 2023-12-31 | $-17 |
| 2023-09-30 | $-7 |
| 2023-06-30 | $-8 |
| 2023-03-31 | $3 |
| 2022-12-31 | $-45 |
| 2022-09-30 | $-10 |
| 2022-06-30 | $-8 |
| 2022-03-31 | $-10 |
| 2021-12-31 | $-36 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-10 |
| 2021-03-31 | $-4 |
| 2020-12-31 | $-6 |
| 2020-09-30 | $-7 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-8 |
| 2019-12-31 | $-8 |
| 2019-09-30 | $-5 |
| 2019-06-30 | $-5 |
| 2019-03-31 | $-4 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $-3 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-4 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-7 |
| 2017-06-30 | $-4 |
| 2017-03-31 | $-5 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-3 |
| 2016-03-31 | $-3 |
| 2015-12-31 | $-4 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-1 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.070B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.621B | 58.04 |
| Tempus AI (TEM) | United States | $12.054B | 0.00 |
| Doximity (DOCS) | United States | $12.025B | 53.35 |
| Hims & Hers Health (HIMS) | United States | $10.818B | 89.50 |
| IRhythm Technologies (IRTC) | United States | $5.361B | 0.00 |
| Hinge Health (HNGE) | United States | $4.529B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.584B | 37.98 |
| Privia Health (PRVA) | United States | $2.580B | 191.09 |
| Phreesia (PHR) | United States | $1.705B | 0.00 |
| Enovis (ENOV) | United States | $1.691B | 8.94 |
| 10x Genomics (TXG) | United States | $1.671B | 0.00 |
| Azenta (AZTA) | United States | $1.471B | 64.16 |
| Schrodinger (SDGR) | United States | $1.456B | 0.00 |
| Omnicell (OMCL) | United States | $1.440B | 27.74 |
| Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
| Claritev (CTEV) | United States | $1.157B | 0.00 |
| Evolent Health (EVH) | United States | $1.053B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
| Veradigm (MDRX) | United States | $0.509B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.504B | 0.00 |
| Standard BioTools (LAB) | United States | $0.498B | 0.00 |
| Talkspace (TALK) | United States | $0.432B | 129.00 |
| Carlsmed (CARL) | $0.365B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.357B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.66 |
| Outset Medical (OM) | United States | $0.235B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.227B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.210B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.199B | 0.00 |
| CapsoVision (CV) | United States | $0.189B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.130B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.90 |
| EUDA Health Holdings (EUDA) | Singapore | $0.095B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |